Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 10:05AM ET
33.54
Dollar change
+0.36
Percentage change
1.08
%
IndexRUT P/E22.67 EPS (ttm)1.48 Insider Own1.08% Shs Outstand174.58M Perf Week3.58%
Market Cap5.82B Forward P/E25.51 EPS next Y1.31 Insider Trans1.96% Shs Float171.62M Perf Month6.11%
Income267.09M PEG1.39 EPS next Q0.23 Inst Own98.85% Short Float2.64% Perf Quarter-1.29%
Sales4.30B P/S1.35 EPS this Y-23.44% Inst Trans3.09% Short Ratio3.64 Perf Half Y2.04%
Book/sh8.14 P/B4.12 EPS next Y16.05% ROA8.14% Short Interest4.53M Perf Year5.97%
Cash/sh1.98 P/C16.92 EPS next 5Y16.28% ROE19.03% 52W Range24.23 - 35.74 Perf YTD-0.45%
Dividend Est.- P/FCF17.66 EPS past 5Y- ROI10.42% 52W High-6.16% Beta1.22
Dividend TTM- Quick Ratio1.33 Sales past 5Y17.51% Gross Margin21.43% 52W Low38.42% ATR (14)0.79
Dividend Ex-Date- Current Ratio1.77 EPS Y/Y TTM79.61% Oper. Margin7.31% RSI (14)59.99 Volatility1.78% 2.60%
Employees5809 Debt/Eq0.82 Sales Y/Y TTM9.06% Profit Margin6.21% Recom1.00 Target Price39.57
Option/ShortYes / Yes LT Debt/Eq0.80 EPS Q/Q23.92% Payout0.00% Rel Volume0.59 Prev Close33.18
Sales Surprise3.31% EPS Surprise12.01% Sales Q/Q9.46% EarningsFeb 22 BMO Avg Volume1.24M Price33.54
SMA203.51% SMA503.91% SMA2004.28% Trades Volume98,948 Change1.08%
Date Action Analyst Rating Change Price Target Change
Feb-27-23Resumed Jefferies Buy $38
Jul-19-21Upgrade Goldman Neutral → Buy $20 → $25
Jan-22-21Initiated Deutsche Bank Buy $22
Jan-11-21Initiated JP Morgan Overweight $21
Dec-15-20Initiated Goldman Neutral $18
Jun-24-20Initiated BofA/Merrill Buy $18
Mar-26-24 05:25PM
Mar-14-24 07:14PM
05:04PM
04:58PM
04:25PM
10:07AM Loading…
Mar-07-24 10:07AM
Feb-23-24 12:34PM
Feb-22-24 11:53PM
08:20AM
07:31AM
07:24AM
07:00AM
Feb-02-24 06:10AM
Jan-22-24 04:05PM
Jan-08-24 07:00AM
05:14AM Loading…
Dec-19-23 05:14AM
Dec-11-23 04:05PM
Dec-06-23 04:11PM
Nov-07-23 04:05PM
Oct-26-23 09:35AM
Oct-25-23 10:27PM
07:05PM
09:56AM
08:15AM
07:08AM
07:00AM
Oct-20-23 11:47AM
Oct-18-23 12:04PM
Oct-16-23 02:53PM
Oct-02-23 05:56AM
03:59PM Loading…
Sep-29-23 03:59PM
08:19AM
Sep-28-23 08:26PM
Sep-27-23 09:24PM
04:05PM
Sep-15-23 09:18AM
Sep-12-23 08:32AM
Sep-08-23 06:23PM
Sep-05-23 07:54AM
Sep-01-23 11:19AM
Aug-31-23 05:00PM
11:40AM
03:34AM
Aug-28-23 09:59AM
Aug-18-23 07:39AM
Aug-14-23 07:03PM
Aug-11-23 09:39AM
Aug-10-23 12:20PM
10:12AM
Aug-03-23 08:06AM
Aug-02-23 07:53AM
07:37AM
Jul-28-23 12:00PM
Jul-27-23 08:25AM
07:20AM
07:00AM
Jul-25-23 05:36AM
Jul-19-23 11:40AM
Jul-06-23 11:22AM
08:00AM
Jun-30-23 01:04PM
Jun-28-23 09:21AM
Jun-27-23 08:18AM
Jun-26-23 01:39PM
09:04AM
08:57AM
08:44AM
Jun-21-23 08:00PM
Jun-11-23 03:45AM
Jun-06-23 01:14PM
08:55AM
Jun-05-23 11:40AM
08:31AM
08:25AM
08:13AM
May-23-23 04:05PM
11:53AM
May-18-23 04:05PM
May-05-23 04:05PM
May-04-23 12:29PM
May-03-23 07:35PM
06:27PM
04:53PM
04:31PM
04:30PM
May-01-23 10:00AM
Apr-27-23 04:05PM
10:02AM
Apr-26-23 08:00PM
Apr-25-23 09:35AM
Apr-18-23 04:05PM
Mar-27-23 11:35AM
Mar-01-23 08:48PM
04:44PM
Feb-26-23 07:47AM
Feb-24-23 05:21AM
Feb-23-23 09:05AM
07:00AM
Feb-22-23 01:43PM
Feb-03-23 09:10AM
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients' homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bavaro MichaelChief Human Resources OfficerFeb 28 '24Sale31.731,98462,94443,428Mar 01 04:28 PM
KRAEMER HARRY M JANSEN JRDirectorFeb 26 '24Buy31.5535,0001,104,352269,528Feb 28 04:41 PM
RADEMACHER JOHN CHARLESChief Executive OfficerFeb 21 '24Option Exercise0.0011,0870705,876Feb 23 06:21 PM
SHAPIRO MICHAEL H.Chief Financial OfficerFeb 17 '24Option Exercise0.003,6520180,570Feb 21 09:55 PM
Bierbower Elizabeth DDirectorOct 30 '23Buy26.373,00079,11013,515Nov 01 05:09 PM
Pate R CarterDirectorAug 17 '23Buy34.321,46550,279106,112Aug 21 05:08 PM
Smyser CollinGC & Corporate SecretaryAug 14 '23Buy34.692,50086,7252,500Aug 15 05:24 PM
KRAEMER HARRY M JANSEN JRDirectorAug 11 '23Buy34.6355,0001,904,518234,528Aug 15 05:26 PM
Smyser CollinGC & Corporate SecretaryMay 19 '23Option Exercise0.00812016,623May 22 04:08 PM